Sign in
EXOZ Stock Price, Chart, Stats & News
eXoZymes, Inc.
Save
eXoZymes, Inc. (EXOZ) does not currently pay a dividend.
57.96M
Market cap
–
Current P/E
–
Forward P/E
EXOZ chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | 0.03% |
ROA | -108.04% |
ROE | -104.53% |
D/E | 0.25x |
Interest coverage ratio | – |
EXOZ valuation
P/E | – |
P/S | – |
P/B | 11.16x |
P/CF | -5.86x |
P/FCF | -5.69x |
P/OCF | -5.86x |
PEG | 1.18x |
EV multiple | -7.82x |
About
eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Similar securities
Based on sector and market capitalization
Report issue